HSP90: a rising star on the horizon of anticancer targets

ISSN： 1479-6694

Source： Future Oncology, Vol.1, Iss.4, 2005-08, pp. : 529-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Hsp90 chaperones as novel molecular targets in prostate cancer

By Altieri Dario C

Future Oncology, Vol. 6, Iss. 4, 2010-04 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite

HSP90: Chaperone-me-not

By Patki J. Pawar S.

Pathology & Oncology Research, Vol. 19, Iss. 4, 2013-10 ,pp. : 631-640

Springer Publishing Company

Access to resources Recommend Favorite

Emerging Hsp90 Inhibitors: From Discovery to Clinic

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 1, 2006-01 ,pp. : 1-8

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Hsp90 Inhibitors as Antitumor Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 761-782

Bentham Science Publishers

Access to resources Recommend Favorite

BTG2: A rising star of tumor suppressors (Review)

International Journal of Oncology, Vol. 46, Iss. 2, 2015-02 ,pp. : 459-464

Spandidos Publications

Access to resources Recommend Favorite